These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Developments in gene therapy for muscular dystrophy. Hartigan-O'Connor D; Chamberlain JS Microsc Res Tech; 2000 Feb 1-15; 48(3-4):223-38. PubMed ID: 10679969 [TBL] [Abstract][Full Text] [Related]
3. Challenges for gene therapy for muscular dystrophy. Mendell JR; Clark KR Curr Neurol Neurosci Rep; 2006 Jan; 6(1):47-56. PubMed ID: 16469271 [TBL] [Abstract][Full Text] [Related]
4. Gene therapy for muscular dystrophies: current status and future prospects. Takeda S; Miyagoe-Suzuki Y BioDrugs; 2001; 15(10):635-44. PubMed ID: 11604045 [TBL] [Abstract][Full Text] [Related]
6. Cell and gene therapy in Duchenne muscular dystrophy. Morgan JE Hum Gene Ther; 1994 Feb; 5(2):165-73. PubMed ID: 7514447 [TBL] [Abstract][Full Text] [Related]
7. Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo. Dunckley MG; Wells DJ; Walsh FS; Dickson G Hum Mol Genet; 1993 Jun; 2(6):717-23. PubMed ID: 8353491 [TBL] [Abstract][Full Text] [Related]
8. Molecular approaches to therapy for Duchenne and limb-girdle muscular dystrophy. Stedman HH Curr Opin Mol Ther; 2001 Aug; 3(4):350-6. PubMed ID: 11525558 [TBL] [Abstract][Full Text] [Related]
9. Molecular targets to treat muscular dystrophies. Kinter J; Sinnreich M Swiss Med Wkly; 2014 Feb; 144():w13916. PubMed ID: 24554202 [TBL] [Abstract][Full Text] [Related]